Aptiom and Abdominal pain upper - a phase IV clinical study of FDA data

Summary:

Abdominal pain upper is reported as a side effect among people who take Aptiom (eslicarbazepine acetate), especially for people who are female, 10-19 old, have been taking the drug for 1 - 2 years also take Banzel, and have Partial seizures.

The phase IV clinical study analyzes which people have Abdominal pain upper when taking Aptiom. It is created by eHealthMe based on reports of 2,380 people who have side effects when taking Aptiom from the FDA, and is updated regularly.

What is Aptiom?

Aptiom has active ingredients of eslicarbazepine acetate. eHealthMe is studying from 2,404 Aptiom users. Check the latest studies of Aptiom.

What is Abdominal pain upper?

Abdominal pain upper is found to be associated with 2,980 drugs and 4,485 conditions by eHealthMe. Check the latest studies of Abdominal pain upper.

On Jul, 13, 2026

2,380 people reported to have side effects when taking Aptiom.
Among them, 13 people (0.55%) have Abdominal pain upper.

Could Aptiom cause Abdominal pain upper?

Among these 13 people:

How long have people been on Aptiom when they have Abdominal pain upper? *

What is the gender of people who have Abdominal pain upper when taking Aptiom? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Abdominal pain upper when taking Aptiom? *

What are other drugs people take besides Aptiom? *

What are other side effects people have besides Abdominal pain upper? *

Seizures (abnormal excessive or synchronous neuronal activity in the brain): 9 people, 69.23%
Nausea (feeling of having an urge to vomit): 2 people, 15.38%
Diarrhea: 2 people, 15.38%
Gastric Ulcer (stomach ulcer): 1 person, 7.69%
Acute Upper Airway Obstruction (blockage occurs in the upper airway): 1 person, 7.69%
Anger: 1 person, 7.69%
Confusional State: 1 person, 7.69%
Drowsiness: 1 person, 7.69%
Flatulence (flatus expelled through the anus): 1 person, 7.69%
Gait Disturbance: 1 person, 7.69%

What are the existing conditions these people have? *

Partial Seizures (seizures which affect only a part of the brain at onset): 7 people, 53.85%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 23.08%
Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 3 people, 23.08%
Simple Partial Seizures (seizures which affect only a small region of the brain): 2 people, 15.38%
Rhinalgia (pain in the nose): 1 person, 7.69%
Rasmussen Encephalitis (a rare inflammatory neurological disease, characterized by frequent and severe seizures, loss of motor skills and speech): 1 person, 7.69%
Pain: 1 person, 7.69%
Insomnia (sleeplessness): 1 person, 7.69%
Headache (pain in head): 1 person, 7.69%
Constipation: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Aptiom and have Abdominal pain upper?

- Check whether Abdominal pain upper is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aptiom:

Aptiom (2,404 reports)

Browse all side effects of Aptiom:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain upper:

Abdominal pain upper (2,980 drugs)

Browse all the conditions that are associated with Abdominal pain upper:

Abdominal pain upper (4,485 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on eslicarbazepine acetate (the active ingredients of Aptiom) and Aptiom (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.